Selomida Haut
Selomida Haut is a medicine authorised by Swissmedic under authorisation number 65359. The authorisation holder is Schwabe Pharma AG. The medicinal product code is Homeopathic medicines and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 09 August 2016 and the authorisation is valid without a time limit. The export lists no ATC code for this medicine.
| Authorisation number | 65359 |
|---|---|
| Name | Selomida Haut |
| Full name | Selomida Haut, Pulver zur Herstellung einer Lösung zum Einnehmen |
| Authorisation holder | Schwabe Pharma AG |
| Medicinal product code | Homeopathic medicines |
| Dispensing category | D · No prescription, with advice |
| ATC code | not stated |
| First authorisation | 09 August 2016 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Selomida Haut, Pulver zur Herstellung einer Lösung zum Einnehmen | D | 09 August 2016 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 x 7,5 | g | - | 20.01.4. | D |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Selomida Haut authorised in Switzerland?
Yes. Selomida Haut is authorised by Swissmedic under authorisation number 65359, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Selomida Haut have?
Selomida Haut is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.
Who is the authorisation holder of Selomida Haut?
The authorisation holder is Schwabe Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.